Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
28.01
-0.50 (-1.77%)
At close: Jul 6, 2026, 4:00 PM EDT
28.65
+0.64 (2.28%)
Pre-market: Jul 7, 2026, 4:09 AM EDT
Genmab Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $38 → $40 | Buy | Reiterates | $38 → $40 | +42.81% | Jul 2, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 30, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $40 | Buy | Maintains | $40 | +42.81% | Jun 30, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $40 | Buy | Reiterates | $40 | +42.81% | Jun 30, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 30, 2026 |
| Wolfe Research | Wolfe Research | Buy Maintains $32 | Buy | Maintains | $32 | +14.24% | Jun 15, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $32 | Hold | Maintains | $32 | +14.24% | May 8, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $34 → $33 | Hold | Maintains | $34 → $33 | +17.82% | May 8, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.